Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Alogliptin helps stimulate the release of insulin ... of Metabolism and Endocrinology Products in the FDA’s Center for Drug Evaluation and Research. Nesina, Kazano, and Oseni were studied ...

If you are already taking both alogliptin and metformin as separate tablets, Nesina Met can replace them in one tablet. Nesina Met is not for patients with type 1 diabetes mellitus or diabetic ...